Seeking Alpha

Orexigen (OREX +17%) is another benificiary of Arena's (ARNA) good fortune today. Contrave is an...

Orexigen (OREX +17%) is another benificiary of Arena's (ARNA) good fortune today. Contrave is an investigational medication OREX has been working on that also focuses on the treatment of obesity, however it's still in the developmental stages.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector